[go: up one dir, main page]

AU2001291744A1 - Arylpiperazine derivatives and their use as psychotropic agents - Google Patents

Arylpiperazine derivatives and their use as psychotropic agents

Info

Publication number
AU2001291744A1
AU2001291744A1 AU2001291744A AU9174401A AU2001291744A1 AU 2001291744 A1 AU2001291744 A1 AU 2001291744A1 AU 2001291744 A AU2001291744 A AU 2001291744A AU 9174401 A AU9174401 A AU 9174401A AU 2001291744 A1 AU2001291744 A1 AU 2001291744A1
Authority
AU
Australia
Prior art keywords
psychotropic agents
arylpiperazine derivatives
arylpiperazine
derivatives
psychotropic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291744A
Inventor
Gerd Bartoszyk
Dieter Dorsch
Rudolf Gottschlich
Jurgen Harting
Christoph Seyfried
Christoph Van Amsterdam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2001291744A1 publication Critical patent/AU2001291744A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001291744A 2000-09-05 2001-08-07 Arylpiperazine derivatives and their use as psychotropic agents Abandoned AU2001291744A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10043659A DE10043659A1 (en) 2000-09-05 2000-09-05 Arylpiperazinderivate
DE10043659 2000-09-05
PCT/EP2001/009108 WO2002020491A1 (en) 2000-09-05 2001-08-07 Arylpiperazine derivatives and their use as psychotropic agents

Publications (1)

Publication Number Publication Date
AU2001291744A1 true AU2001291744A1 (en) 2002-03-22

Family

ID=7655009

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291744A Abandoned AU2001291744A1 (en) 2000-09-05 2001-08-07 Arylpiperazine derivatives and their use as psychotropic agents

Country Status (15)

Country Link
US (1) US20040014972A1 (en)
EP (1) EP1326842A1 (en)
KR (1) KR20030024913A (en)
CN (1) CN1452614A (en)
AU (1) AU2001291744A1 (en)
BR (1) BR0113581A (en)
CA (1) CA2421219A1 (en)
CZ (1) CZ2003809A3 (en)
DE (1) DE10043659A1 (en)
MX (1) MXPA03001826A (en)
NO (1) NO20030998L (en)
PL (1) PL360289A1 (en)
SK (1) SK3612003A3 (en)
WO (1) WO2002020491A1 (en)
ZA (1) ZA200302636B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231507D1 (en) 2001-07-20 2010-07-01 Psychogenics Inc TREATMENT OF HYPERACTIVITY DISORDERS AND ATTENTION DEFICITS
WO2004082570A2 (en) * 2003-03-17 2004-09-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2)
US20060142276A1 (en) * 2003-06-23 2006-06-29 Yukihiro Ohno Therapeutic agent for senile dementia
ES2250000B1 (en) * 2004-09-29 2007-06-01 Medichem, S.A. PROCEDURE FOR PREPARATION OF ZIPRASIDONE.
ES2250001B1 (en) * 2004-09-29 2007-06-01 Medichem, S.A. PROCESS FOR THE PURIFICATION OF ZIPRASIDONA.
KR100660142B1 (en) * 2005-01-24 2006-12-20 이명섭 Dry sand production method and system
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
TW200808730A (en) * 2006-06-09 2008-02-16 Wyeth Corp Process for synthesizing piperazine-piperidine compounds
CL2007003410A1 (en) * 2006-11-28 2008-04-11 Wyeth Corp COMPOUNDS DERIVED FROM 5-FLUORO-8- {4- [4- (6-METOXIQUINOLIN-8-IL) PIPERAZIN-1-IL] PIPERIDIN-1-IL} QUINOLINE; PREPARATION PROCEDURE; INTERMEDIARY COMPOUNDS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF TRAST
MY156814A (en) 2007-03-15 2016-03-31 Novartis Ag Organic compounds and their uses
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148392D0 (en) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocyclic Compounds
AU5343498A (en) * 1997-01-21 1998-08-07 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compounds and medicinal use thereof
ES2128266B1 (en) * 1997-07-08 2000-01-16 Vita Invest Sa THIOPHENE AND BENZOTIOFEN DERIVATIVE COMPOUNDS AND RELEVANT USE AND COMPOSITION.
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists

Also Published As

Publication number Publication date
SK3612003A3 (en) 2003-07-01
KR20030024913A (en) 2003-03-26
CZ2003809A3 (en) 2003-06-18
DE10043659A1 (en) 2002-03-14
BR0113581A (en) 2003-07-15
PL360289A1 (en) 2004-09-06
ZA200302636B (en) 2004-09-08
CN1452614A (en) 2003-10-29
WO2002020491A1 (en) 2002-03-14
US20040014972A1 (en) 2004-01-22
NO20030998D0 (en) 2003-03-04
CA2421219A1 (en) 2003-03-03
MXPA03001826A (en) 2003-06-04
EP1326842A1 (en) 2003-07-16
NO20030998L (en) 2003-03-04

Similar Documents

Publication Publication Date Title
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
IL155071A0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
HUP0301146A3 (en) 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
AU2002235128A1 (en) Expression miniarrays and uses thereof
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0203961A3 (en) 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001269175A1 (en) Diamino phenothiazine derivatives and composition comprising same
AU2001289758A1 (en) Novel indole derivatives and their use as medicaments
IL153930A0 (en) Novel indole derivatives and their use as medicaments
AU2001291744A1 (en) Arylpiperazine derivatives and their use as psychotropic agents
AU2001230355A1 (en) Benzoxazole derivatives and their use as pesticides
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2001277561A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
AU2002210853A1 (en) Hetero-anellated ortho-aminophenols and their use as dye components
AU4432001A (en) Trityl-type compounds and their use